Physician profile
Tracy L Asher
NPI 1366445405
$1,563.96
in general payments reported to CMS, 2019-2025
25 companies · $574 in 2025
The $574 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.46 · 2020: $26.00 · 2021: $287 · 2022: $181 · 2023: $213 · 2024: $247 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $279.90 | 2022-2025 | Freestyle Libre 3 |
| Abbvie INC. | $273.75 | 2021-2025 | Qulipta, Ubrelvy |
| Si-Bone, INC. | $145.19 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.63 | 2025 | |
| Novo Nordisk INC | $86.25 | 2020-2025 | Wegovy |
| Lilly USA, LLC | $79.75 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Exact Sciences Corporation | $74.42 | 2024-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $67.18 | 2024-2025 | Farxiga, Airsupra |
| Pfizer INC. | $64.05 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $45.22 | 2025 | Spravato |
| Amgen INC. | $44.49 | 2019-2025 | Otezla, Repatha, Otezla |
| Nevro Corp. | $43.03 | 2021 | |
| Eisai INC. | $35.67 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $33.40 | 2025 | Caplyta |
| Sumitomo Pharma America, INC. | $29.24 | 2024 | Gemtesa |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $21.81 | 2023 | Trelegy Ellipta |
| Boston Scientific Corporation | $20.41 | 2024 | Varithena Administration Pack |
| Otsuka America Pharmaceutical, INC. | $19.66 | 2023 | Rexulti |
| Allergan, INC. | $17.82 | 2019 | |
| Biogen, INC. | $17.64 | 2025 | Skyclarys |
| Dexcom, INC. | $16.15 | 2024 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $16.05 | 2025 | Inspire |
| Astellas Pharma US INC | $13.02 | 2021 | |
| Merck Sharp & Dohme LLC | $12.69 | 2021 | |
| Bardy Diagnostics, INC. | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Asher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.